hospitalization and not evident at admission. For some infections, e.g., invasive fungal infections, this time period is highly debatable. Care-related conditions, such as exposure to invasive devices (i.e., mechanical ventilation, central venous or urinary tract catheterization) and treatments, facilitate infections by heightening impaired immunity. Regarding IA risk, extensive reviews have described factors associated with this infection and underlined that the risk is low for patients without immunodefi ciency and outside any context of care [2, 3] .
Introduction
Ubiquitous worldwide, Aspergillus is associated with community or hospital-acquired (nosocomial) infections. Thus, it may be diffi cult to identify the respective contributions of these two environments to the risk of colonization or infection. After revisiting the risk of invasive aspergillosis (IA) from environmental exposure, this short review will focus on methodological questions related to the epidemiology of community or nosocomial IA. Clinical conditions, such as aspergilloma, allergenic diseases, including allergic bronchopulmonary aspergillosis and other localizations, will not be discussed [1] .
Usually, hospital-acquired or nosocomial infections (NI) have been defi ned as infections with onset 48 hours after S25 soil and rural areas are a major source of contamination. Other reservoirs are compost heaps, hay barns and bird droppings.
In human habitations, Aspergillus is present in dust, infrequently-cleaned places, particularly attics and cellars, potted ornamental plants and fl owers, in shutters, carpets and vacuum cleaners. This organism has also been identifi ed in some foods, especially peppers and other spices, tea, biscuits and fruits. A recent study revealed fi lamentous fungi including A. fumigatus , in tobacco and marijuana [6 -8] . Some of these reservoirs are not limited to the community and are found in hospitals.
In hospitals, additional reservoirs have been identifi ed in false ceilings, roller-blind casings, fi reproofi ng material and contaminated ventilation or inadequate fi ltration. This fungal organism also contaminates some hospital material, such as adhesive tapes, arm bands, plaster [6,9 -12] . Some investigations have discovered opportunistic fungi in water from sinks and showerheads in some American or Norwegian hospitals. Water contamination by fi lamentous fungi is nonsystematic and perhaps related to intake modality [13] . However, this source-reservoir is still being debated [5, 14] .
Transmission routes
Inhalation of fungal conidia is the primary acquisition route for aspergillosis [2, 4, 15] . The spores are relatively small, with sizes ranging from 2 -5 μ m, depositing in the upper and lower respiratory tracts [16] . Aspergillus spores are released from different reservoirs and often remain in the air for prolonged periods due to their tiny size. Several studies have reported variability of Aspergillus conidia concentrations in outdoor air with means ranging from 0 to around 20 colony-forming units/mm 3 or more [6] . More recent investigations have not found correlations between the number of airborne Aspergillus conidia and the seasons [5, 6] . There is no consensus on safe concentrations of airborne conidia; their levels are probably correlated to the severity of immunosuppression.
Very high concentrations have been detected in country air near compost heaps or hay barns. Different technical interventions, such as fi lters and false ceilings can increase fungal aero-contamination. Construction work is known to liberate large quantities of conidia, and the concentration of airborne fungi can rise dramatically to more than 100 spores/mm 3 . Outbreaks of nosocomial IA have often been linked with construction, demolition and renovation activities in and around hospitals [5, 6, 17, 18] . In a review of 53 outbreaks, Vonberg and Gastmeier observed that 49% of them were associated with construction/demolition [19] . Direct contamination of wounds or skin in low birth weight infants or burn patients has also been reported [5, 6] .
Although air transmission is the most frequent route of infection, others might exist. Direct contact transmission has been associated with contamination of adhesive tape, gauze and intravascular catheters [4, 6, 11] . Transmission by exposure to contaminated water and aerosolization of spores is controversial [13, 14] .
Molecular characterization and comparison of fungal isolates from patients and their environments will contribute to understanding the epidemiology [20, 21] . However, it is often diffi cult to demonstrate a relationship between patients and environmental fungi because of very signifi cant genetic diversity of Aspergillus and samples taken after patient contamination. It is also unclear whether patients are colonized or infected before admission to hospital. Questions regarding nosocomial and community IA raise at least two methodological issues, i.e., incubation and causality.
Natural history and incubation
While little is known about IA incubation [22] , it has been historically defi ned by Sartwell [23] as the time period required for multiplication of the parasite organism within the host up to the threshold at which the parasite population is large enough to produce symptoms in the host. This defi nition remains valid today [24] and in this instance, the parasite is understood to be Aspergillus spp., mainly the inhaled conidia, which are the units with initial contact with the host while the symptoms are related to IA. Durations of the incubation period from 3 days to more than 100 days after hospitalization have been reported [25] . A cut-off of 7 days has often been used as an incubation period for fungal infections [26] , but some studies have defi ned nosocomial IA as that which occurs from the fi rst day after hospital admission [27] and others as that which is present 10 days after admission [28] . These defi nitions were used more for clinical plausibility and comparability between studies than based on systematic analysis of observational or experimental data. Indeed, the incubation period preceding IA is still unknown. Moreover, the potential impact of Aspergillus colonization before hospitalization on incubation remains an issue which is still broadly discussed [29, 30] . Indeed, any invasive aspergillosis occurring during hospitalization is diffi cult to describe as hospital acquired or ' hospital revealed ' . Furthermore, the role of a previous colonization with Aspergillus needs further prospective observational studies taking into account the host (i.e., immunodepression, underlying disease) and environmental (i.e., airway ventilation, water exposures) characteristics related to the risk of IA.
Different approaches might bring some information on the issue of the incubation. Statistical modeling using back calculation could permit an estimation of the incubation period when a specifi c date of the exposure to Aspergillus spores can be documented (i.e., IA outbreak during building renovation) [23] . However, such estimations will be uncertain due to the heterogeneity of disease presentation IA could be modulated by community or hospital exposure and with treatment improvements, immunosuppressed patients could return to a satisfactory ' normal ' life.
Disease progression from one stage to another should take the duration of each stage into account (Fig. 2) . The analysis must consider not only the date of exposure and colonization but also the duration of these periods as they will represent the difference between the older date of exposure minus the closest date of exposure before onset. Similar calculations of colonization could be proposed, but are diffi cult in practice. Figure 2 depicts the theoretical distributions of durations of exposure, the durations of colonization and the distribution of time of IA diagnosis. Based on these theoretical distributions, it is obvious that we have to document if these periods occurred in the community or hospital. For each period distribution, both scenarios should be discussed to propose adapted investigations, as well as preventive and prophylactic measures.
Causality: association between hospital stay and IA occurrence
Preventive measures against IA are contingent on hospital and community acquisition of the disease. It is also important to research causal criteria for hospital-acquired IA. A major issue is to assess if hospital stay is a risk factor for IA. The answer is not easy because; (i) Aspergillus spores are present in hospital and community, (ii) many confounders can be linked to hospital stay, and (iii) the estimation of this risk has not been fully explored. For instance, acute leukemia patients hospitalized for induction chemotherapy undergo prolonged neutropenia, a well-known host-related factor for IA [3, 25, 38, 39] . Is hospital exposure to Aspergillus suffi cient to cause IA? If neutropenia is a component of IA, is it a necessary cause? The same question arises for corticoid exposure, transplantation, mild immunosuppression, and other risk factors for IA [2, 3] .
To begin dealing with the association between hospital stay and IA occurrence, we can apply the causal perspectives defi ned by Hill [40] . First, the strength of the association is correlated with the relative risk of the outcome, i.e., IA incidence in hospitalized vs. non-hospitalized populations. Thus, IA incidence in the general population was 12.4/100,000 in 3 American counties between 1992 and 1993 [41], whereas it was much higher in hospitals [41 -45] . In addition, the attack rate for patients with acute leukemia was most often between 5% and 25% [42, 43] . However, no study has formally estimated the relative risk with and without hospitalization. Second, there is consistency in the association between hospitalization and IA occurrence. Indeed, a review found 53 outbreaks involving 458 patients [19] and several surveillance studies determined that IA cases were regularly diagnosed in hematological units and of the diffi culty in the determination of the period of acute exposure and the unknown status regarding previous colonization of the host [31] . Repeated testing of antigen or PRC after admission might also provide interesting results, even if the test has some detection limits [32, 33] . Animal experimental models could help for the estimation of this delay because the exposure time is precisely known (when the animals are inoculated with Aspergillus spores), and autopsies permit histopathological data on the nature of the infection. Several animal models have been developed [34, 35] to explore the pathogenesis of aspergillosis disease, but they did not focus on incubation. The use of murine models could provide further information on this issue. Lastly, the natural history of the exposure to this invasive disease is diffi cult to assess as Aspergillus spp. are commensal fungi. The probability of disease depends on individual immunity, the colonization of the respiratory tracts is not constant, and the inocula can vary over seasons or place [36] . These factors could lead to different incubation periods for the same etiologic agent but no formal argument can support this hypothesis.
On the other hand, the incubation period can be contributed to only by the community, only by the hospital or could be the result of these two environments. The identifi cation of exposure sources needs appropriate protective measures for different settings. For simplifi cation, disease progression can be divided into four stages, i.e., exposure, colonization, clinical disease onset, and possible dissemination (Fig. 1) . This simplistic disease course should be discussed because proof of colonization warrants valid screening, and most investigations have focused on the time interval between presumed exposure and clinical disease onset [3 -5] . However, for each stage illustrated in Fig. 1 , we have to consider the risk factors or environmental determinants (the hospital or the community) impacting the host, including underlying disease with or without immunosuppression [2], genetic predisposition [37] and Aspergillus virulence. Thus, the individual risk of 
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[43 -45] or intensive care units [46] . Third, the specifi city of hospital exposure is not a constant criterion because (i) it can lead to a wide range of NI [47] , and (ii) IA has been observed without previous hospital stay [28] . Fourth, the temporality criteria were met in more than 50% of IA cases in 1 study [28] , but other cases were obviously not related to hospital acquisition. Fifth, the observation of a correlation between Aspergillus environmental load and IA involved a biological gradient [48] but other studies did not fi nd any correlation [20] . Moreover, simultaneous isolation of the same Aspergillus strain in hospital environments and patient samples [21, 49] reinforces the biological gradient concept. Sixth, the association is plausible since the etiological agent is present in the hospital environment and progression of the infectious process is known [2, 50] . Seventh, underlying diseases could interfere in the association between hospital stay and IA occurrence. Indeed, neutropenia, transplantation and other host-related factors could jeopardize coherence of the association [51, 52] because of their interaction with IA risk factors. Experimental evidence suggested a link between environmental changes and decreased IA incidence in ' protected rooms ' [53 -55] or increased IA incidence during hospital renovations [17, 18] . Finally, analogies with other pulmonary infectious diseases could be made, but the transmission route, reservoir and infectious process related to IA seem to be unique. Temporality and biological plausibility are important components of a causal association between hospital stay and IA. Moreover, strength of the effect and experimental evidence are strong arguments for hospital acquisition of IA. Indeed, several reports provided experimental evidence for such infections as quasi-experimental studies show decreased IA incidence when controlling for hospital environment (by positive pressure isolation or higheffi ciency air fi ltration) [53 -55] . Also, besides hostspecifi c factors that can be linked with hospital stay and possibly with the hospital acquisition of IA [2, 3, 38, 39] , hospitalization seems to constitute an independent risk factor for IA.
While exposure to Aspergillus spores is universal, many causal arguments for hospital acquisition of IA can be put forward (Table 1) . However, the natural history of IA Ϫ from exposure to colonization and disease Ϫ is complex, and the precise place of hospital involvement in this process is still not directly known.
